RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Alcohol-Related Disorders
Accession: DOID:9004354
browse the term
Definition: Disorders related to or resulting from abuse or mis-use of alcohol.
Synonyms: exact_synonym: Alcohol-Related Disorder
primary_id: MESH:D019973
G
Bdnf
brain derived neurotrophic factor
sexual_dimorphism
ISO
protein:altered expression:brain protein:altered expression:frontal cortex,hippocampus,occipital cortex protein:altered expression:cerebral cortex
RGD
PMID:10837897 PMID:18652597 PMID:14604765
RGD:401965408 , RGD:401976540 , RGD:401976539
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Cartpt
CART prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22823101
NCBI chr13:100,034,991...100,037,191
Ensembl chr13:100,034,997...100,037,599
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:30118883
RGD:13782287
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cd4
CD4 antigen
sexual_dimorphism
ISO
associated with Mycobacterium Infections;protein:decreased expression:spleen (rat) protein:increases expression:spleen (rat)
RGD
PMID:9744851 PMID:8214423
RGD:407446372 , RGD:407446376
NCBI chr 6:124,841,656...124,865,210
Ensembl chr 6:124,841,655...124,865,184
G
Crh
corticotropin releasing hormone
sexual_dimorphism
ISO
mRNA:increased expression:fetus, thymus
RGD
PMID:8977428
RGD:405878076
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
G
Fos
FBJ osteosarcoma oncogene
ISO
protein:increased expression:liver
RGD
PMID:9731567
RGD:405101375
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Jun
jun proto-oncogene
ISO
protein:increased expression:liver
RGD
PMID:9731567
RGD:405101375
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Ngf
nerve growth factor
ISO IEP
protein:altered expression:brain protein:decreased expression:entorhinal cortex protein:increased expression:frontal cortex,cerebellar vermis protein:increased expression:cerebral cortex protein:increased expression:thalamus
RGD
PMID:10837897 PMID:10440485 PMID:18652597 PMID:14604765 PMID:21277941
RGD:401965408 , RGD:401976542 , RGD:401976540 , RGD:401976539 , RGD:401976494
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
ISO
protein:decreased expression:brain protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
Ntf3
neurotrophin 3
ISO
protein:increased expression:hippocampus,cerebellar vermis
RGD
PMID:18652597
RGD:401976540
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Ntrk1
neurotrophic tyrosine kinase, receptor, type 1
ISO
protein:altered expression:brain protein:decreased expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
ISO
protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Ntrk3
neurotrophic tyrosine kinase, receptor, type 3
ISO
protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr 7:77,825,711...78,228,865
Ensembl chr 7:77,825,707...78,387,760
G
Oprk1
opioid receptor, kappa 1
treatment
ISO
RGD
PMID:20962231
RGD:401850591
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
Pomc
pro-opiomelanocortin-alpha
sexual_dimorphism
ISO
mRNA:decreased expression:fetus, thymus
RGD
PMID:8977428
RGD:405878076
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
ClinVar Annotator: match by term: Alcohol sensitivity, acute | ClinVar Annotator: match by term: Susceptibility to hangover
ClinVar
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:25741868 PMID:28492532 PMID:33355142 More...
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Adcyap1
adenylate cyclase activating polypeptide 1
susceptibility
ISO
DNA:SNP:: (rs2856966) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965
G
Adh1
alcohol dehydrogenase 1 (class I)
susceptibility
ISO
ClinVar Annotator: match by term: Alcohol dependence associated with other drug dependencies; DNA:SNPs:CDS: (rs904096)
ClinVar OMIM RGD
PMID:3397059 PMID:3758060 PMID:10090900 PMID:15863807 PMID:17718394 PMID:17923853 PMID:27151647 More...
RGD:405650603
NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
RGD
PMID:20077761
RGD:401827938
NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653
G
Adra2a
adrenergic receptor, alpha 2a
susceptibility
ISO
DNA:SNP:promoter: C-1291G (rs1800544) (human) associated with stress-related disorder; mRNA:decreased expression:hypothalamus (rat)
RGD
PMID:21070505 PMID:26121187
RGD:401976462 , RGD:401976544
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
G
Ago1
argonaute RISC catalytic subunit 1
susceptibility
ISO
DNA:SNP:intron:A>G(rs595961)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr 4:126,328,805...126,362,500
Ensembl chr 4:126,328,805...126,362,376
G
Ago2
argonaute RISC catalytic subunit 2
susceptibility
ISO
DNA:SNP:promoter:A>C(rs4961280)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr15:72,967,693...73,056,777
Ensembl chr15:72,967,693...73,056,784
G
Ahr
aryl-hydrocarbon receptor
ISO
mRNA:decreased expression:duodenum:
RGD
PMID:34454169
RGD:405866377
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
ClinVar Annotator: match by term: Alcohol dependence DNA:SNP: :1510G>A (human)
ClinVar RGD
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:33355142 PMID:20077761 PMID:16679777 More...
RGD:401827938 , RGD:401827936
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Angpt1
angiopoietin 1
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs10090742)
RGD
PMID:27151647
RGD:405650603
NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
G
Ankk1
ankyrin repeat and kinase domain containing 1
susceptibility
ISO
DNA:polymorphism:exon: DNA:SNP,haplotype:exon:rs1800497(human)
RGD
PMID:28574012 PMID:23443985
RGD:401959222 , RGD:401959307
NCBI chr 9:49,326,494...49,338,341
Ensembl chr 9:49,326,494...49,338,321
G
Ar
androgen receptor
severity
ISO
DNA:repeats:N-terminal
RGD
PMID:19231085
RGD:407424612
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Arrb2
arrestin, beta 2
ISO
mRNA:decreased expression:nucleus accumbens
RGD
PMID:34919270
RGD:401938593
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
G
Avpr1b
arginine vasopressin receptor 1B
ISO
RGD
PMID:21309953
RGD:14700679
NCBI chr 1:131,526,908...131,539,740
Ensembl chr 1:131,526,977...131,539,738
G
Bdnf
brain derived neurotrophic factor
treatment
ISO
RGD
PMID:34453945 PMID:32579730
RGD:401959604 , RGD:401959610
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Bmal1
basic helix-loop-helix ARNT like 1
susceptibility
ISO
DNA:SNP::(rs6486120) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333
G
Bmal2
basic helix-loop-helix ARNT like 2
susceptibility
ISO
DNA:SNPs, haplotype:: (rs7958822,rs4964057) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 6:146,696,230...146,735,027
Ensembl chr 6:146,697,553...146,735,027
G
Bptf
bromodomain PHD finger transcription factor
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs11870068)
RGD
PMID:27151647
RGD:405650603
NCBI chr11:106,923,907...107,022,982
Ensembl chr11:106,923,907...107,022,953
G
Cacna1c
calcium channel, voltage-dependent, L type, alpha 1C subunit
ISO
mRNA, protein:increased expression:amygdala, hippocampus (rat) protein:increased expression:inferior colliculus (human)
RGD
PMID:27905406 PMID:25556199
RGD:152985537 , RGD:152985539
NCBI chr 6:118,564,201...119,174,345
Ensembl chr 6:118,564,201...119,173,851
G
Cck
cholecystokinin
susceptibility
ISO
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:9622381
RGD:407419865
NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760
G
Cdk20
cyclin dependent kinase 20
susceptibility
ISO
DNA:SNP:: (rs560019) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr13:64,580,133...64,587,536
Ensembl chr13:64,580,128...64,589,587
G
Chat
choline O-acetyltransferase
IDA
protein:decreased expression:hippocampus,septum,striatum
RGD
PMID:8436061
RGD:401976285
NCBI chr14:32,130,160...32,187,866
Ensembl chr14:32,130,160...32,187,946
G
Chrna3
cholinergic receptor, nicotinic, alpha polypeptide 3
susceptibility
ISO
DNA:missense:exons:p.R37H,p.E363D(human)
RGD
PMID:24057674
RGD:405849397
NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846
G
Chrnb3
cholinergic receptor, nicotinic, beta polypeptide 3
susceptibility
ISO
DNA:missense:exons:multiple(human)
RGD
PMID:24057674
RGD:405849397
NCBI chr 8:27,858,688...27,889,758
Ensembl chr 8:27,858,739...27,889,758
G
Clock
clock circadian regulator
exacerbates
IMP
RGD
PMID:23722243
RGD:401976471
NCBI chr 5:76,357,715...76,452,675
Ensembl chr 5:76,357,715...76,452,639
G
Comt
catechol-O-methyltransferase
susceptibility sexual_dimorphism onset disease_progression
ISO
associated with Alzheimer's disease; DNA:SNP:cd: P.V158M G>A (rs4680) (human) DNA:SNPs,haplotypes:: (rs165774,rs4680) (human) DNA:SNPs,haplotype:exon 4: p.V158M (rs4680) (human) DNA:SNP:cd: p.V158M (rs4680) (human) DNA:SNP:cd: p.V158M (human) associated with major depressive disorder; DNA:SNP:cd: p.V158M (human) DNA:polymorphism:exon 4: p.V158M (rs4680)(human) associated with schizophrenia; DNA:promoter:Hypermethylation associated with Trauma and Stressor Related Disorders ; DNA:polymorphism:exon: p.V158M (human)
RGD
PMID:25491588 PMID:22208661 PMID:16499480 PMID:24390676 PMID:16648777 PMID:20860878 PMID:25035107 PMID:16984965 PMID:20517217 PMID:11244495 PMID:31150143 PMID:10698363 More...
RGD:11073926 , RGD:401959747 , RGD:401959300 , RGD:401940156 , RGD:401940155 , RGD:401940149 , RGD:401940148 , RGD:401940146 , RGD:401940133 , RGD:401940131 , RGD:401940120 , RGD:401940118
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Cpe
carboxypeptidase E
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs10517844) DNA:SNP:CDS: (rs13706874) (human)
RGD
PMID:27151647 PMID:20201924
RGD:405650603 , RGD:405650609
NCBI chr 8:65,045,576...65,146,143
Ensembl chr 8:65,045,576...65,146,088
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO IDA
DNA:SNP:exon:rs35349697 protein:increased phosphorylation:prefrontal cortex (rat) mRNA,protein:decreased expression:hippocampus
RGD
PMID:24704376 PMID:19324071 PMID:21951632 PMID:32579730 PMID:34453945 PMID:37031608 More...
RGD:401938627 , RGD:401901600 , RGD:401959743 , RGD:401959610 , RGD:401959604 , RGD:401959603
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
ISO
protein:increased expression:frontal cortex, microsome
RGD
PMID:25504503
RGD:405100234
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
ISO
protein:increased expression:brain
RGD
PMID:12354285
RGD:401901262
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
RGD
PMID:9927612
RGD:405650696
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Dgcr8
DGCR8, microprocessor complex subunit
susceptibility
ISO
DNA:SNP:3���-UTR:G>T(rs1640299)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr16:18,071,812...18,107,115
Ensembl chr16:18,071,812...18,107,110
G
Drd1
dopamine receptor D1
ISO
RGD
PMID:17360123
RGD:405100958
NCBI chr13:54,205,202...54,209,677
Ensembl chr13:54,205,202...54,209,724
G
Drd2
dopamine receptor D2
onset susceptibility
ISO
DNA:insertion, deletion:promoter: DNA:SNP: :rs1800498(human)
RGD
PMID:23238469 PMID:36825486
RGD:401959213 , RGD:401959301
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Drd4
dopamine receptor D4
no_association
ISO
DNA:repeats:exon:
RGD
PMID:9342196
RGD:401959738
NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
G
Fkbp5
FK506 binding protein 5
susceptibility
IMP ISO
associated with stress-related disorder;DNA:SNP:: (rs1360780) (human) associated with stress-related disorder;mRNA:affects expression:ventral tegmental area,cingulate cortex, nucleus accumbens( rat) DNA:SNPs:intron,3'utr: (rs1360780, rs3800373)
RGD
PMID:27527158 PMID:27709495 PMID:27709495 PMID:27527158
RGD:401976484 , RGD:401976487 , RGD:401976487 , RGD:401976484
NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
G
Fmn1
formin 1
ISO
associated with other drug dependencies; DNA:SNPs:CDS: (rs3910705)
RGD
PMID:27151647
RGD:405650603
NCBI chr 2:113,158,029...113,547,113
Ensembl chr 2:113,158,081...113,547,112
G
Fos
FBJ osteosarcoma oncogene
treatment
ISO
protein:increased expression:granular insular cortex, paraventricular nucleus of thalamus, prefrontal cortex
RGD
PMID:29926762 PMID:17723286 PMID:14574439 PMID:17360123
RGD:405100722 , RGD:405295497 , RGD:405101697 , RGD:405100958
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fosb
FBJ osteosarcoma oncogene B
treatment
ISO
protein:increased expression:nucleus accumbens (rat) associated with Sleep Deprivation;protein:increased expression:brain
RGD
PMID:20626732 PMID:19324071 PMID:33662520
RGD:401851075 , RGD:401901600 , RGD:401900733
NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
susceptibility treatment
ISO IMP
DNA:SNP, haplotype:intron: C>G (rs29220) (human) DNA:SNP:Exon 11: T1974C (Human) mRNA:decreased expression:hippocampus (human) mRNA:decreased expression:hippocampus (rat) DNA:SNP:intron: (rs29220) (human) DNA:SNP:intron: (rs29253) (human)
RGD
PMID:22253714 PMID:26727527 PMID:36095322 PMID:36095322 PMID:10412185 PMID:29968397 PMID:25191505 More...
RGD:401900163 , RGD:11552767 , RGD:401976442 , RGD:401976442 , RGD:401959601 , RGD:401940102 , RGD:401940100
NCBI chr17:37,356,888...37,385,197
Ensembl chr17:37,356,858...37,385,959
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:22253714
RGD:401900163
NCBI chr 4:46,662,318...46,991,714
Ensembl chr 4:46,662,305...46,991,873
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
susceptibility
ISO
ClinVar Annotator: match by term: Alcohol dependence
ClinVar OMIM
PMID:25741868
NCBI chr 5:71,115,735...71,253,192
Ensembl chr 5:71,114,940...71,253,192
G
Gabrb3
GABRB3, gamma-aminobutyric acid type A receptor subunit beta 3
susceptibility
ISO
DNA:SNPs: :
RGD
PMID:14745296
RGD:405866351
NCBI chr 7:57,240,266...57,478,550
Ensembl chr 7:57,069,440...57,478,550
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
ISO
DNA:SNPs, haplotype:introns:IVS9+99C>A, IVS10+3145A>G (rs211014, rs211013) (human) mRNA:decreased expression:hippocampus (human) mRNA:increased expression:hippocampus (rat)
RGD
PMID:15630072 PMID:22253714 PMID:22253714
RGD:402463959 , RGD:401900163 , RGD:401900163
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Gad1
glutamate decarboxylase 1
susceptibility onset
ISO
DNA:SNPs, haplotype:5'UTR,IVS:Rs3749034,Rs2270335,Rs10439259(human) DNA:SNPs: haplotype:multiple:rs1978340(human)
RGD
PMID:17067345 PMID:19111404
RGD:401900127 , RGD:401900129
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
G
Gad2
glutamic acid decarboxylase 2
susceptibility
ISO
DNA:SNP::-243A>G (rs2236418)
RGD
PMID:17034009
RGD:401900120
NCBI chr 2:22,512,262...22,583,889
Ensembl chr 2:22,512,217...22,583,886
G
Gdnf
glial cell line derived neurotrophic factor
treatment
ISO
protein:decreased expression:serum
RGD
PMID:15659598 PMID:19232578 PMID:20553781 PMID:24801661
RGD:405820207 , RGD:405850246 , RGD:405849399 , RGD:405849388
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Gemin4
gem nuclear organelle associated protein 4
susceptibility
ISO
DNA:SNP:Promoter:C>T(rs910924)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr11:76,101,397...76,108,398
Ensembl chr11:76,101,397...76,108,490
G
Ggt1
gamma-glutamyltransferase 1
ISO
protein:increased activity:plasma,liver,intestine:
RGD
PMID:6113606
RGD:14701046
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
ameliorates
IMP
RGD
PMID:33955100
RGD:405649731
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Grin2a
glutamate receptor, ionotropic, NMDA2A (epsilon 1)
susceptibility ameliorates
ISO IMP
DNA:repeats:promoter:(GT)n DNA:mutation:cds:A825W(mouse)
RGD
PMID:21507155 PMID:33052417 PMID:29953905
RGD:401938633 , RGD:401938638 , RGD:401938635
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
G
Grm8
glutamate receptor, metabotropic 8
susceptibility
ISO
DNA:SNPs:intron 1: (rs886003, rs17862325) (human)
RGD
PMID:25978827
RGD:11070870
NCBI chr 6:27,275,120...28,135,094
Ensembl chr 6:27,275,118...28,135,177
G
Gstt1
glutathione S-transferase, theta 1
ISO
RGD
PMID:29582627
RGD:14700988
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
ISO
mRNA:increased expression:Brodmann (1909) area 9 associated with nicotine dependence;DNA:SNPs:enhancer:multiple DNA:SNP: :140G>C
RGD
PMID:22176604 PMID:23216389 PMID:19060480
RGD:401900608 , RGD:405849412 , RGD:401900293
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
Htr1b
5-hydroxytryptamine (serotonin) receptor 1B
susceptibility onset sexual_dimorphism no_association
ISO
DNA:SNP:5'UTR:-161A>T (human) DNA:SNP: :861G>C (human) DNA:SNP: :861G>C(human) DNA:SNP,haplotype:promoter:161A>T (human) DNA:SNP:promoter:rs11568817 (human)
RGD
PMID:12022963 PMID:21906503 PMID:11104852 PMID:11827742 PMID:21172311 PMID:22005095 More...
RGD:405650693 , RGD:405847406 , RGD:405847401 , RGD:405818273 , RGD:405650698 , RGD:405650694
NCBI chr 9:81,510,344...81,515,885
Ensembl chr 9:81,510,344...81,515,881
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
disease_progression treatment no_association
ISO
DNA:SNP: :102T>C (rs6313) protein:decreased expression:agranular insular cortex, cingulate cortex, frontal cortex DNA:SNP:promoter:-1438G>A (rs6311)
RGD
PMID:23321485 PMID:8822536 PMID:15080502 PMID:19328219 PMID:19060480 PMID:21930285 More...
RGD:401900291 , RGD:401900739 , RGD:401900737 , RGD:401900304 , RGD:401900293 , RGD:401900297
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Htr3a
5-hydroxytryptamine (serotonin) receptor 3A
exacerbates treatment susceptibility
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human) DNA:SNPs:enhancer, exon: (rs1150226, rs1176713) (human) DNA:SNPs, haplotype:multiple (human) mRNA:increased expression:prefrontal cortex (rat) DNA:SNP:exon 1: (rs33940208) (human)
RGD
PMID:27144979 PMID:23897038 PMID:24590108 PMID:25722691 PMID:23757001
RGD:404976874 , RGD:405096433 , RGD:404976878 , RGD:404976876 , RGD:404976875
NCBI chr 9:48,810,513...48,822,451
Ensembl chr 9:48,810,513...48,822,399
G
Il1rn
interleukin 1 receptor antagonist
ISO
protein:increased expression:blood
RGD
PMID:14634483
RGD:405878079
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Kcnb2
potassium voltage gated channel, Shab-related subfamily, member 2
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs2251898)
RGD
PMID:27151647
RGD:405650603
NCBI chr 1:15,357,149...15,793,975
Ensembl chr 1:15,357,478...15,793,974
G
Lep
leptin
severity
IDA ISO IEP
DNA:hypermethylation:promoter protein:decreased expression:serum
RGD
PMID:29912265 PMID:19884906 PMID:29912265
RGD:21201248 , RGD:407424613 , RGD:21201248
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:34453945
RGD:401959604
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:34453945
RGD:401959604
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Ncam1
neural cell adhesion molecule 1
susceptibility
ISO
DNA:SNPs:exon:
RGD
PMID:17761687
RGD:405866369
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
G
Ngf
nerve growth factor
ISO
protein:increased expression:serum protein:decreased expression:sciatic nerve protein:decreased expression:plasma
RGD
PMID:17434673 PMID:8733743 PMID:16737466
RGD:401965399 , RGD:401976493 , RGD:401965409
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
ISO
protein:altered expression:brain,neuron
RGD
PMID:7609866
RGD:401976553
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
Npy
neuropeptide Y
susceptibility
ISO
DNA:SNP:cd: p.L7P (rs16139) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
ISO
mRNA:altered expression:central amygdaloid nucleus (rat)
RGD
PMID:28461696
RGD:401960064
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
Nrm
nurim (nuclear envelope membrane protein)
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs2269705)
RGD
PMID:27151647
RGD:405650603
NCBI chr17:36,171,987...36,176,292
Ensembl chr17:36,172,210...36,176,294
G
Nrxn3
neurexin III
susceptibility
ISO
DNA:SNP,haplotype:Chr14:rs8019381, rs760288|rs8019381|2rs2293847 (human)
RGD
PMID:17804423
RGD:405096431
NCBI chr12:88,689,454...90,301,709
Ensembl chr12:88,689,646...90,301,709
G
Nucb2
nucleobindin 2
ISO
mRNA,protein:decreased expression:hippocampus
RGD
PMID:37031608
RGD:401959603
NCBI chr 7:116,103,579...116,139,823
Ensembl chr 7:116,103,604...116,139,819
G
Oprd1
opioid receptor, delta 1
ISO
DNA:SNP,haplotype:intron 1 (rs2298896|rs421300), multiple GCAAT (human)
RGD
PMID:17622222
RGD:401976552
NCBI chr 4:131,834,980...131,872,042
Ensembl chr 4:131,838,037...131,871,797
G
Oprk1
opioid receptor, kappa 1
no_association
ISO
DNA:SNPs:intron:multiple DNA:SNP,haplotype:multiple (multiple GGCTTCT) (human) mRNA:increased expression:orbitofrontal cortex DNA:SNP: :rs6473797 (human)
RGD
PMID:16924269 PMID:17622222 PMID:21955155 PMID:24035285
RGD:401850571 , RGD:401976552 , RGD:401850584 , RGD:401850579
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
Oprm1
opioid receptor, mu 1
no_association treatment sexual_dimorphism
ISO
DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human) DNA:SNP: :rs1799971 (human)
RGD
PMID:16679777 PMID:24035285 PMID:30748046 PMID:11424981 PMID:35992511 PMID:17374034 PMID:18250251 PMID:20077761 PMID:20077761 More...
RGD:401827936 , RGD:401850579 , RGD:401831038 , RGD:401827953 , RGD:401827952 , RGD:401827944 , RGD:11097488 , RGD:401827938 , RGD:401827938
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
Pde4b
phosphodiesterase 4B, cAMP specific
susceptibility
ISO
DNA:SNP:: (rs1937443) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
G
Pdyn
prodynorphin
no_association disease_progression
ISO
DNA:SNP, hypermethylation:promoter:rs2235751 (human) mRNA, protein:increased expression:dorsolateral prefrontal cortex, orbitofrontal cortex DNA:SNP: :rs1997794 (human) DNA:SNP, hypermethylation:dorsolateral prefrontal cortex:rs2281285 (human) DNA:SNP: :rs2281285 (human) DNA:SNPs: :multiple DNA:SNPs, haplotypes:multiple
RGD
PMID:28336495 PMID:21955155 PMID:24035285 PMID:21521424 PMID:26502829 PMID:16924269 PMID:24223163 PMID:23101464 More...
RGD:401850551 , RGD:401850584 , RGD:401850579 , RGD:401850575 , RGD:11535796 , RGD:401850571 , RGD:401850565 , RGD:401850560
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Per2
period circadian clock 2
ISO
DNA, mRNA:hypermethylation, decreased expression:blood DNA:hypermethylation:blood, promoter
RGD
PMID:30597578 PMID:31329297
RGD:405878075 , RGD:405878078
NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046
G
Pknox2
Pbx/knotted 1 homeobox 2
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs750338)
RGD
PMID:27151647
RGD:405650603
NCBI chr 9:36,802,278...37,058,637
Ensembl chr 9:36,802,278...37,058,703
G
Pomc
pro-opiomelanocortin-alpha
no_association
ISO
DNA:SNP: :rs934778 (human) DNA:hypermethylation:promoter:blood mRNA:decreased expression:hypothalamus mRNA:increased expression:pituitary gland mRNA:increased expression:blood, lymphocyte DNA:hypermethylation:blood, promoter DNA, mRNA:hypermethylation, decreased expression:blood mRNA:increased expression:blood, lymphocytes
RGD
PMID:24035285 PMID:20191296 PMID:11981131 PMID:7662043 PMID:14634483 PMID:31329297 PMID:30597578 PMID:9426836 More...
RGD:401850579 , RGD:407431644 , RGD:407424597 , RGD:406179436 , RGD:405878079 , RGD:405878078 , RGD:405878075 , RGD:405878074
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Prl
prolactin
treatment
ISO
RGD
PMID:11418230
RGD:401959332
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Rgs6
regulator of G-protein signaling 6
ISO
associated with other drug dependencies; DNA:SNPs:CDS: (rs11621871)
RGD
PMID:27151647
RGD:405650603
NCBI chr12:82,663,325...83,208,835
Ensembl chr12:82,635,066...83,208,830
G
Slc29a1
solute carrier family 29 (nucleoside transporters), member 1
IAGP
OMIM:103780
MouseDO
NCBI chr17:45,896,126...45,910,544
Ensembl chr17:45,896,126...45,910,532
G
Slc6a1
solute carrier family 6 (neurotransmitter transporter, GABA), member 1
susceptibility
ISO
DNA:insertion:promoter:: (human)
RGD
PMID:26727527
RGD:11552767
NCBI chr 6:114,259,735...114,294,491
Ensembl chr 6:114,259,596...114,294,493
G
Slc6a2
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
susceptibility
ISO
DNA:SNPs,haplotypes:intron: (rs36020,rs36029) (human)
RGD
PMID:21070505
RGD:401976462
NCBI chr 8:93,687,100...93,728,295
Ensembl chr 8:93,686,707...93,728,295
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
disease_progression
ISO
DNA:VNTR
RGD
PMID:18552399
RGD:401900298
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Tas2r118
taste receptor, type 2, member 118
ISO
OMIM
NCBI chr 6:23,969,160...23,970,059
Ensembl chr 6:23,969,160...23,970,059
G
Tbx19
T-box 19
susceptibility
ISO
DNA:SNP:: (rs1003502) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr 1:164,965,403...164,988,342
Ensembl chr 1:164,965,424...164,988,342
G
Ttc12
tetratricopeptide repeat domain 12
susceptibility
ISO
DNA:SNPs:introns,exon:
RGD
PMID:17761687
RGD:405866369
NCBI chr 9:49,348,261...49,397,572
Ensembl chr 9:49,348,263...49,397,525
G
Atp2a1
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
ISO
RGD
PMID:14506614
RGD:1581765
NCBI chr 7:126,045,032...126,062,245
Ensembl chr 7:126,045,030...126,062,280
G
Acads
acyl-Coenzyme A dehydrogenase, short chain
susceptibility
ISO
DNA:SNP:: (rs1799958) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 5:115,248,358...115,257,405
Ensembl chr 5:115,248,358...115,257,405
G
Adh1
alcohol dehydrogenase 1 (class I)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16404797
NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
G
Adh5
alcohol dehydrogenase 5 (class III), chi polypeptide
ISO
RGD
PMID:8462548
RGD:5129091
NCBI chr 3:138,142,961...138,161,260
Ensembl chr 3:138,148,854...138,161,260
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16404797 PMID:17590986 PMID:10780266
RGD:734551
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Ankk1
ankyrin repeat and kinase domain containing 1
severity
ISO
DNA:polymorphism: :rs1800497(human) DNA:SNP,haplotype: :rs11604671, rs4938015 (human)
RGD
PMID:32889058 PMID:21936764
RGD:401940151 , RGD:401959296
NCBI chr 9:49,326,494...49,338,341
Ensembl chr 9:49,326,494...49,338,321
G
Arc
activity regulated cytoskeletal-associated protein
IDA
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr15:74,540,930...74,544,419
Ensembl chr15:74,540,932...74,544,419
G
Bdnf
brain derived neurotrophic factor
ISO IEP
protein:decreased expression:plasma protein:decreased expression:cerebellum, hippocampus protein:altered expression:brain mRNA:decreased expression:hippocampus mRNA,protein:decreased expression:hippocampus, plasma (rat) protein:decreased expression:plasma (human)
RGD
PMID:32135570 PMID:19100286 PMID:15307153 PMID:32497709 PMID:30277635 PMID:30277635 More...
RGD:35673317 , RGD:401976492 , RGD:401965482 , RGD:401950485 , RGD:401938665 , RGD:401938665
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Calb1
calbindin 1
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 4:15,881,264...15,906,709
Ensembl chr 4:15,881,264...15,908,064
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
IEP
mRNA:increased expression:prefrontal cortex
RGD
PMID:28714806
RGD:18337277
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
G
Camk4
calcium/calmodulin-dependent protein kinase IV
ISO
protein:decreased expression:brain, cingulate gyrus
RGD
PMID:11181917
RGD:401959326
NCBI chr18:33,067,995...33,328,820
Ensembl chr18:33,067,984...33,324,281
G
Cast
calpastatin
ISO
protein:increased expression:gastrocnemius (rat)
RGD
PMID:28800153
RGD:405100967
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
G
Cat
catalase
treatment
ISO
associated with diabetes; protein:decreased activity;testis, epididymis (rat) associated with cardiomyopathy associated with cognitive disorder; protein:altered activity:hippocampus (rat) associated with diabetes;protein:decreased activity:liver, kidney (rat)
RGD
PMID:22596042 PMID:25541261 PMID:7195942 PMID:27367870 PMID:21713042
RGD:405255659 , RGD:405255664 , RGD:405255663 , RGD:405255662 , RGD:405255660
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cckar
cholecystokinin A receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9922984
NCBI chr 5:53,855,827...53,865,046
Ensembl chr 5:53,855,118...53,865,047
G
Cdk20
cyclin dependent kinase 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr13:64,580,133...64,587,536
Ensembl chr13:64,580,128...64,589,587
G
Chrna3
cholinergic receptor, nicotinic, alpha polypeptide 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846
G
Chrna5
cholinergic receptor, nicotinic, alpha polypeptide 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr 9:54,888,112...54,918,704
Ensembl chr 9:54,888,164...54,915,063
G
Chrna6
cholinergic receptor, nicotinic, alpha polypeptide 6
severity
ISO
DNA:haplotypes: :
RGD
PMID:19698703
RGD:405849410
NCBI chr 8:27,893,240...27,903,972
Ensembl chr 8:27,893,240...27,903,972
G
Clock
clock circadian regulator
susceptibility
ISO
DNA:SNP:: (rs2412648) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 5:76,357,715...76,452,675
Ensembl chr 5:76,357,715...76,452,639
G
Cnr1
cannabinoid receptor 1
sexual_dimorphism
ISO
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Comt
catechol-O-methyltransferase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :rs4680(human) DNA:polymorphism::
CTD RGD
PMID:10395222 PMID:32889058 PMID:10395222
RGD:401940151 , RGD:401940114
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Creb1
cAMP responsive element binding protein 1
sexual_dimorphism
ISO
mRNA, protein:decreased expression:amygdala protein:increased phosphorylation:liver protein:altered expression, altered phosphorylation:liver, nucleus
RGD
PMID:29991681 PMID:31262967 PMID:22269225
RGD:401938626 , RGD:401959334 , RGD:401959317
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Crebbp
CREB binding protein
ISO
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
G
Crh
corticotropin releasing hormone
ISO
mRNA:increased expression:central amygdaloid nucleus (rat)
RGD
PMID:20060104
RGD:5508173
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
G
Crhr1
corticotropin releasing hormone receptor 1
IMP
RGD
PMID:11988580
RGD:734822
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO IMP
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma, extracellular exosome
CTD RGD
PMID:20843640 PMID:23819932 PMID:29404485 PMID:29404485
RGD:14700915 , RGD:14700911 , RGD:14700911
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Dbh
dopamine beta hydroxylase
no_association
ISO
DNA:polymorphism:cds:g.444G>A (human) DNA:polymorphism:5' utr:g.-1021C>T (human)
RGD
PMID:16252068 PMID:16133787
RGD:1625571 , RGD:1625572
NCBI chr 2:27,055,519...27,073,216
Ensembl chr 2:27,055,245...27,073,212
G
Dcx
doublecortin
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr X:142,638,838...142,716,392
Ensembl chr X:142,638,838...142,716,307
G
Dlg4
discs large MAGUK scaffold protein 4
IEP
associated with Prenatal Exposure Delayed Effects and anxiety disorder:mRNA,protein:decreased expression:brain (mouse)
RGD
PMID:30016666
RGD:401959614
NCBI chr11:69,908,029...69,938,107
Ensembl chr11:69,907,768...69,938,348
G
Drd2
dopamine receptor D2
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Drd4
dopamine receptor D4
treatment susceptibility
ISO
DNA:repeats:exon: associated with peer pressure;DNA:repeats:exon:
RGD
PMID:25640830 PMID:26307243
RGD:11064848 , RGD:401959598
NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
G
Ep300
E1A binding protein p300
ISO
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Ercc1
excision repair cross-complementing rodent repair deficiency, complementation group 1
ISO
RGD
PMID:23095216
RGD:10045658
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
G
Fgf2
fibroblast growth factor 2
ISO
RGD
PMID:28821667 PMID:31375540
RGD:405855870 , RGD:405855874
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fmr1
fragile X messenger ribonucleoprotein 1
ISO
mRNA:increased expression:cerebellum
RGD
PMID:34453331
RGD:401938639
NCBI chr X:67,722,144...67,761,569
Ensembl chr X:67,722,147...67,761,569
G
Fos
FBJ osteosarcoma oncogene
treatment
ISO IEP
protein:increased expression:brain protein:increased expression:parvocellular oculomotor nucleus
RGD
PMID:14741756 PMID:29210146 PMID:11164784
RGD:405255650 , RGD:405295495 , RGD:405255652
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fosb
FBJ osteosarcoma oncogene B
treatment
ISO IEP
protein:increased expression:dorsal striatum (mouse) protein:increased expression:brain (mouse)
RGD
PMID:22792289 PMID:27380261 PMID:9835277
RGD:401851082 , RGD:401901287 , RGD:401901184
NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976
G
Fshb
follicle stimulating hormone beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr17:37,356,888...37,385,197
Ensembl chr17:37,356,858...37,385,959
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
susceptibility
ISO
DNA:SNP:intron: (rs2900512) (human)
RGD
PMID:28118741
RGD:401940105
NCBI chr 4:46,662,318...46,991,714
Ensembl chr 4:46,662,305...46,991,873
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
susceptibility
ISO
DNA:SNPs:multiple: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22253714 PMID:15024690
RGD:6480257
NCBI chr 5:71,115,735...71,253,192
Ensembl chr 5:71,114,940...71,253,192
G
Gabrb3
GABRB3, gamma-aminobutyric acid type A receptor subunit beta 3
susceptibility
ISO
DNA:CA repeats: :(human)
RGD
PMID:9858031
RGD:405866342
NCBI chr 7:57,240,266...57,478,550
Ensembl chr 7:57,069,440...57,478,550
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Gata4
GATA binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20585342
NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
G
Gdnf
glial cell line derived neurotrophic factor
treatment
ISO
protein:increased expression:serum associated with Tobacco Use Disorder;mRNA:decreased expression:ventral tegmental area DNA:hypomethylation:nucleus accumbens
RGD
PMID:25623403 PMID:28559549 PMID:22238721 PMID:31710958
RGD:401965480 , RGD:405850249 , RGD:405849387 , RGD:405820205
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12747453
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Ghsr
growth hormone secretagogue receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23977009
NCBI chr 3:27,425,500...27,433,384
Ensembl chr 3:27,425,500...27,432,159
G
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr12:78,264,099...78,731,546
Ensembl chr12:78,273,153...78,731,546
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
IEP ISO
protein:increased phosphorylation:lumbar spinal cord (mouse) protein:decreased expression:neocortex (rat) protein:increased expression, increased phosphorylation:cingulate cortex (rat) protein:increased expression:nucleus accumbens (mouse) protein:increased expression:nucleus accumbens (rat)
RGD
PMID:28585190 PMID:12036520 PMID:34280506 PMID:21041654 PMID:21041654
RGD:405100727 , RGD:405820203 , RGD:405818275 , RGD:405650686 , RGD:405650686
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
ISO
RGD
PMID:14573320
RGD:1642372
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
ISO
RGD
PMID:14573320 PMID:16911840
RGD:1642372 , RGD:1642200
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
Hdac2
histone deacetylase 2
ISO
RGD
PMID:23485013
RGD:9590265
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
treatment
ISO
RGD
PMID:9631953
RGD:401900760
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
Htr1b
5-hydroxytryptamine (serotonin) receptor 1B
sexual_dimorphism onset no_association
ISO
associated with attention deficit hyperactivity disorder;DNA:SNP: :rs11568817(human) DNA:SNP: :rs13212041 (human) DNA:SNPs: :multiples (human)
RGD
PMID:28923721 PMID:30774345 PMID:11496363
RGD:405650695 , RGD:405847403 , RGD:405818272
NCBI chr 9:81,510,344...81,515,885
Ensembl chr 9:81,510,344...81,515,881
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:dorsal raphe, nucleus accumbens mRNA, protein:decreased expression:cerebral cortex, liver
CTD RGD
PMID:9631953 PMID:9347073 PMID:9347075 PMID:20501057
RGD:401900760 , RGD:401900742 , RGD:401900740 , RGD:401900301
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Htr2c
5-hydroxytryptamine (serotonin) receptor 2C
treatment
ISO
RGD
PMID:24041931
RGD:401900761
NCBI chr X:145,745,509...145,980,273
Ensembl chr X:145,745,509...145,980,273
G
Htr3a
5-hydroxytryptamine (serotonin) receptor 3A
HDA
DNA:hypermethylation, hypomethylation:promoter: (mouse)
RGD
PMID:22834954
RGD:404976877
NCBI chr 9:48,810,513...48,822,451
Ensembl chr 9:48,810,513...48,822,399
G
Htr3b
5-hydroxytryptamine (serotonin) receptor 3B
susceptibility
ISO
DNA:SNP:cds:rs1176744(human)
RGD
PMID:20838391
RGD:6480660
NCBI chr 9:48,846,308...48,876,290
Ensembl chr 9:48,846,308...48,876,290
G
Htr7
5-hydroxytryptamine (serotonin) receptor 7
ISO
DNA:SNP:intron: (rs7916403) (human)
RGD
PMID:21184583
RGD:150429835
NCBI chr19:35,935,815...36,035,533
Ensembl chr19:35,936,134...36,034,907
G
Igf2
insulin-like growth factor 2
ISO
protein:decreased expression:plasma (human)
RGD
PMID:30277635
RGD:401938665
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Il10
interleukin 10
ISO
mRNA:increased expression:liver
RGD
PMID:22269225
RGD:401959317
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
ISO
DNA:SNP:promoter:rs2836016 (human)
RGD
PMID:21307845
RGD:6483053
NCBI chr16:94,545,839...94,798,719
Ensembl chr16:94,549,495...94,798,560
G
Lhb
luteinizing hormone beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
G
Maoa
monoamine oxidase A
susceptibility
ISO
RGD
PMID:15900229
RGD:1600720
NCBI chr X:16,485,937...16,554,051
Ensembl chr X:16,485,937...16,554,057
G
Mapk1
mitogen-activated protein kinase 1
ISO
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk14
mitogen-activated protein kinase 14
IDA
protein:increased expression, increased phosphorylation:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk3
mitogen-activated protein kinase 3
ISO
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
ISO
RGD
PMID:31262967
RGD:401959334
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mcm5
minichromosome maintenance complex component 5
ISO
RGD
PMID:23095216
RGD:10045658
NCBI chr 8:75,836,096...75,855,067
Ensembl chr 8:75,836,197...75,855,067
G
Mir191
microRNA 191
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 9:108,445,518...108,445,591
Ensembl chr 9:108,445,518...108,445,591
G
Mir195a
microRNA 195a
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr11:70,125,868...70,125,961
Ensembl chr11:70,125,868...70,125,961
G
Mir206
microRNA 206
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 1:20,749,234...20,749,306
Ensembl chr 1:20,749,234...20,749,306
G
Mir30a
microRNA 30a
onset
ISO
RGD
PMID:32135570
RGD:35673317
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mki67
antigen identified by monoclonal antibody Ki 67
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mmp2
matrix metallopeptidase 2
ISO
RGD
PMID:24966898
RGD:13207311
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:24966898
RGD:13207311
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Ncam1
neural cell adhesion molecule 1
sexual_dimorphism treatment
ISO
mRNA:decreased expression:hippocampus (rat) associated with chronic stress in female rats
RGD
PMID:30277635 PMID:27894930 PMID:16207289
RGD:401938665 , RGD:401959751 , RGD:401959613
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
G
Ngf
nerve growth factor
ISO IEP
protein:increased expression:serum protein:decreased expression:cerebral cortex, hippocampus protein:decreased expression:brain
RGD
PMID:25623403 PMID:19100286 PMID:15307153
RGD:401965480 , RGD:401976492 , RGD:401965482
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Npy
neuropeptide Y
ISO
DNA:deletion:intron:g.4666_4674del (rat) CTD Direct Evidence: marker/mechanism DNA:missense mutation: :p.L7P (human)
CTD RGD
PMID:17572454 PMID:15749341 PMID:12215082
RGD:1357412 , RGD:10430830
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Npy2r
neuropeptide Y receptor Y2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18828811
NCBI chr 3:82,445,688...82,455,404
Ensembl chr 3:82,445,690...82,455,391
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
treatment sexual_dimorphism
ISO
RGD
PMID:29437012 PMID:30171933 PMID:33007359
RGD:401965466 , RGD:401976281 , RGD:401966865
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
Nrg1
neuregulin 1
sexual_dimorphism
ISO
in female, associated with stressful life event;DNA:SNP: :rs6994992(human)
RGD
PMID:27353026
RGD:405100235
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Ntf3
neurotrophin 3
ISO
protein:decreased expression:plasma (human) protein:increased expression:brain mRNA,protein:decreased expression:hippocampus, plasma (rat)
RGD
PMID:30277635 PMID:15307153 PMID:30277635
RGD:401938665 , RGD:401965482 , RGD:401938665
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
IDA ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:protein:decreased acetylation:brain
RGD
PMID:30016666 PMID:8840027
RGD:401959614 , RGD:401965407
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Oprd1
opioid receptor, delta 1
ISO
associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat) DNA:SNPs, haplotype:intron 1:multiple (human)
RGD
PMID:28511993 PMID:24533225 PMID:7501658
RGD:401976432 , RGD:402525443 , RGD:401976439
NCBI chr 4:131,834,980...131,872,042
Ensembl chr 4:131,838,037...131,871,797
G
Oprk1
opioid receptor, kappa 1
severity susceptibility no_association
ISO
DNA:SNP, haplotype: :rs6473797 (human) associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat) DNA:SNP: :rs6473797 (human) DNA:SNP: :rs997917 (human)
RGD
PMID:31004399 PMID:28511993 PMID:37177778 PMID:37177778
RGD:401831037 , RGD:401976432 , RGD:401850581 , RGD:401850581
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
Oprl1
opioid receptor-like 1
ISO
RGD
PMID:11814626
RGD:9835016
NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
G
Oprm1
opioid receptor, mu 1
treatment no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human) DNA:missense mutations, SNP:exon, intron:p.A6V, p.S147C, p.N40D (118A>G) (rs 1799971), IVS2+691G>C (human) DNA:SNP: :rs510769
CTD RGD
PMID:12815747 PMID:32772383 PMID:9399694 PMID:26042510
RGD:401827947 , RGD:401827934 , RGD:401827930
NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198
G
Pde4b
phosphodiesterase 4B, cAMP specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
G
Pdyn
prodynorphin
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:hippocampus, granule cell DNA:SNPs: :rs2281285, rs2225749, rs910080 (human) DNA:SNP: :rs2281285 (human) DNA, mRNA:SNP, decreased expression:promoter, dorsolateral prefrontal cortex:rs1997794 (human) associated with cocaine dependence;DNA, mRNA:SNPs, haplotype:3' utr:rs910080, rs910079, rs2235749 (human)
CTD RGD
PMID:17559549 PMID:18923396 PMID:1589146 PMID:37177778 PMID:36099111 PMID:29925858 PMID:18923396 More...
RGD:401851059 , RGD:401850581 , RGD:401850566 , RGD:401850559 , RGD:401850550
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Penk
preproenkephalin
ISO
mRNA:increased expression:frontal lobe:
RGD
PMID:22703995
RGD:10003152
NCBI chr 4:4,133,536...4,138,815
Ensembl chr 4:4,133,531...4,138,819
G
Pomc
pro-opiomelanocortin-alpha
ISO
protein:decreased expression:brain (rat) mRNA:increased expression: hypothalamus, pituitary gland, shell of nucleus accumbens
RGD
PMID:18162070 PMID:22724395
RGD:401976284 , RGD:405878072
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Rpl18a
ribosomal protein L18A
ISO
mRNA:decreased expression:parietal cortex
RGD
PMID:11244494
RGD:11038708
NCBI chr 8:71,347,366...71,350,087
Ensembl chr 8:71,347,366...71,350,056
G
Shbg
sex hormone binding globulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
susceptibility
ISO
protein:decreased activity: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15520362 PMID:17000009 PMID:20838391
RGD:6480660
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Snca
synuclein, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18055133
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
Sod1
superoxide dismutase 1, soluble
ISO
associated with diabetes; protein:decreased activity;testis, epididymis (rat)
RGD
PMID:25541261
RGD:405255664
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sox2
SRY (sex determining region Y)-box 2
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
G
Spi1
Spi-1 proto-oncogene
treatment
ISO
protein:decreased expression:alveolar macrophage
RGD
PMID:16272341 PMID:21447000
RGD:9586723 , RGD:9586725
NCBI chr 2:90,912,750...90,946,104
Ensembl chr 2:90,912,735...90,946,101
G
Spn
sialophorin
IDA
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr 7:126,731,404...126,743,785
Ensembl chr 7:126,731,404...126,736,995
G
St6gal1
beta galactoside alpha 2,6 sialyltransferase 1
severity
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:17697868
RGD:10043133
NCBI chr16:23,043,478...23,179,100
Ensembl chr16:23,043,490...23,179,100
G
Syp
synaptophysin
sexual_dimorphism
ISO
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr X:7,504,819...7,519,495
Ensembl chr X:7,504,710...7,519,495
G
Tacr1
tachykinin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19204064
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
G
Tacr3
tachykinin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422838
NCBI chr 3:134,534,768...134,640,342
Ensembl chr 3:134,534,768...134,640,340
G
Tas2r118
taste receptor, type 2, member 118
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16385453 PMID:17250611
NCBI chr 6:23,969,160...23,970,059
Ensembl chr 6:23,969,160...23,970,059
G
Tas2r138
taste receptor, type 2, member 138
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17250611
NCBI chr 6:40,589,249...40,590,244
Ensembl chr 6:40,589,249...40,590,244
G
Tbx19
T-box 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 1:164,965,403...164,988,342
Ensembl chr 1:164,965,424...164,988,342
G
Timeless
timeless circadian clock 1
susceptibility
ISO
DNA:SNP:: (rs2291738) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr10:128,067,932...128,088,810
Ensembl chr10:128,067,934...128,088,810
G
Tph1
tryptophan hydroxylase 1
ISO
RGD
PMID:15654285
RGD:1580464
NCBI chr 7:46,294,065...46,321,961
Ensembl chr 7:46,294,065...46,321,961
G
Trf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11000917 PMID:21792595
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Vip
vasoactive intestinal polypeptide
susceptibility
ISO
DNA:SNPs, haplotype:: (rs3823082,rs688136) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617
G
Cck
cholecystokinin
susceptibility
ISO
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:10235270
RGD:406351024
NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760
G
Cnr1
cannabinoid receptor 1
ISO
RGD
PMID:11841893
RGD:1626329
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Ngf
nerve growth factor
ISO
protein:increased expression:serum
RGD
PMID:17434673
RGD:401965399
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
RGD
PMID:16318954
RGD:5688289
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Cacna1d
calcium channel, voltage-dependent, L type, alpha 1D subunit
susceptibility
ISO
mRNA, protein:increased expression:inferior colliculus (rat)
RGD
PMID:25556199
RGD:152985539
NCBI chr14:29,761,898...30,213,113
Ensembl chr14:29,761,896...30,213,412
G
Drd2
dopamine receptor D2
susceptibility
ISO
DNA:SNP:exon:A>G(human)
RGD
PMID:23238469
RGD:401959213
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Pdyn
prodynorphin
IEP
mRNA:increased expression:brain
RGD
PMID:15869750
RGD:401850576
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Slc29a1
solute carrier family 29 (nucleoside transporters), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283641
NCBI chr17:45,896,126...45,910,544
Ensembl chr17:45,896,126...45,910,532
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Bdnf
brain derived neurotrophic factor
severity
ISO
RGD
PMID:20553781
RGD:405849399
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Bmal1
basic helix-loop-helix ARNT like 1
severity
ISO
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333
G
Clock
clock circadian regulator
severity
ISO
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 5:76,357,715...76,452,675
Ensembl chr 5:76,357,715...76,452,639
G
Cry1
cryptochrome circadian regulator 1
severity
ISO
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr10:84,967,564...85,020,918
Ensembl chr10:84,967,564...85,020,928
G
Cry2
cryptochrome circadian regulator 2
ISO
mRNA:decreased expression:Peripheral blood mononuclear cell (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 2:92,233,991...92,264,426
Ensembl chr 2:92,233,991...92,264,388
G
Cyp2c38
cytochrome P450, family 2, subfamily c, polypeptide 38
no_association treatment
ISO
DNA:SNPs::CYP2C19*2 (681G>A,rs4244285), CYP2C19*3 (636G>A, rs4986893),CYP2C19*17 (-806C>T, rs12248560) (human) DNA:SNP:promoter:CYP2C19*17 (-806C>T,rs12248560)(human) DNA:SNP:cds:CYP2C19*2 (681G>A,rs4244285)(human)
RGD
PMID:27099220 PMID:30325732 PMID:31957548
RGD:401960863 , RGD:401960882 , RGD:401960880
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
G
Drd4
dopamine receptor D4
severity
ISO
DNA:repeats:exon:
RGD
PMID:20359751
RGD:401959612
NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
G
Fkbp5
FK506 binding protein 5
severity
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:24603855
RGD:401976481
NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
G
Fos
FBJ osteosarcoma oncogene
treatment
ISO
protein:altered expression:brain
RGD
PMID:26727528 PMID:31778691
RGD:405101372 , RGD:405255665
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fosb
FBJ osteosarcoma oncogene B
disease_progression
IEP
protein:increased expression:primary motor cortex, secondary motor cortex, ventral tegmental area (mouse)
RGD
PMID:24355551
RGD:401851085
NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
ISO
mRNA, protein:increased expression:hippocampus (rat)
RGD
PMID:12488536
RGD:402528882
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Gdnf
glial cell line derived neurotrophic factor
ISO
mRNA, DNA:altered expression, hypomethylation:brain
RGD
PMID:31710958
RGD:405820205
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
ISO
protein:increased phosphorylation:lateral habenular nucleus (rat)
RGD
PMID:28865912
RGD:405650672
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Ngf
nerve growth factor
ISO
protein:increased expression:plasma
RGD
PMID:8727238
RGD:401976550
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Npy1r
neuropeptide Y receptor Y1
ISO
mRNA:decreased expression:hippocampus, cerebral cortex (rat)
RGD
PMID:20028355
RGD:10448926
NCBI chr 8:67,149,595...67,159,452
Ensembl chr 8:67,149,844...67,159,444
G
Per1
period circadian clock 1
severity
ISO
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr11:68,985,934...69,000,791
Ensembl chr11:68,986,043...69,000,786
G
Per2
period circadian clock 2
severity
ISO
mRNA:decreased expression:Peripheral blood mononuclear cell (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046
G
Pomc
pro-opiomelanocortin-alpha
ISO
mRNA:increased expression:hypothalamus protein:decreased expression:plasma
RGD
PMID:11981131 PMID:31117084
RGD:407424597 , RGD:407431638
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Prl
prolactin
treatment
ISO
RGD
PMID:3816539
RGD:401960110
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Aif1
allograft inflammatory factor 1
ISO
protein:increased expression:cortex, hippocampus (rat)
RGD
PMID:18585922
RGD:2313030
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
G
Cirbp
cold inducible RNA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24223948
NCBI chr10:80,001,824...80,008,620
Ensembl chr10:80,001,819...80,008,620
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 9:49,326,494...49,338,341
Ensembl chr 9:49,326,494...49,338,321
G
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Foxo4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:100,297,855...100,304,479
Ensembl chr X:100,298,134...100,304,479
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr 5:121,357,323...121,506,633
Ensembl chr 5:121,358,282...121,506,640
G
Ppa2
pyrophosphatase (inorganic) 2
ISO
ClinVar Annotator: match by term: Sudden cardiac failure, alcohol-induced
OMIM ClinVar
PMID:24033266 PMID:25741868 PMID:27523597 PMID:27523598 PMID:28492532 PMID:30384889 PMID:31705601 PMID:33028643 PMID:34400813 More...
NCBI chr 3:133,015,842...133,083,996
Ensembl chr 3:133,015,871...133,083,996
G
Ace
angiotensin I converting enzyme
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22497828
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Nos1
nitric oxide synthase 1, neuronal
ISO
protein:decreased expression:skeletal muscle, membrane
RGD
PMID:17607508
RGD:1642138
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:heart myocardium
RGD
PMID:18783396
RGD:2301868
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Rxra
retinoid X receptor alpha
ISO
RGD
PMID:19791468
RGD:2317465
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
G
Slc25a4
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
ISO
mRNA, protein:decreased expression:myocardium
RGD
PMID:21169901
RGD:9681464
NCBI chr 8:46,660,205...46,664,099
Ensembl chr 8:46,659,834...46,664,321
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:plasma
RGD
PMID:16115302
RGD:5686674
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adipor2
adiponectin receptor 2
treatment
ISO IEP
RGD
PMID:26115886 PMID:18755807 PMID:27220557 PMID:22013387
RGD:25330099 , RGD:25824943 , RGD:25824939 , RGD:25440493
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
G
Adra2a
adrenergic receptor, alpha 2a
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
severity treatment susceptibility
ISO IEP
human transgene in mouse model protein:altered processing:liver (mouse) DNA:missense mutation:cds:p.E504K (human)
RGD
PMID:17058263 PMID:25457208 PMID:29156373 PMID:29063269
RGD:1599041 , RGD:15036811 , RGD:15036805 , RGD:14696776
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Ar
androgen receptor
severity
ISO
RGD
PMID:11447013
RGD:407424619
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Arrb2
arrestin, beta 2
ameliorates
ISO IMP
protein:increased expression:hepatocyte
RGD
PMID:33871024 PMID:33871024
RGD:401938594 , RGD:401938594
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
G
Atg7
autophagy related 7
exacerbates ameliorates
IMP
RGD
PMID:31235522 PMID:34303881
RGD:407445921 , RGD:407445922
NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
G
Birc3
baculoviral IAP repeat-containing 3
ISO
protein:increased expression:liver (human)
RGD
PMID:29307797
RGD:153297819
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
G
C1qc
complement component 1, q subcomponent, C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35789393
NCBI chr 4:136,617,115...136,620,225
Ensembl chr 4:136,617,115...136,620,376
G
Ccl2
C-C motif chemokine ligand 2
treatment
IEP
RGD
PMID:25557254 PMID:30611703
RGD:14995489 , RGD:407424594
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccr2
C-C motif chemokine receptor 2
treatment
IEP
RGD
PMID:25557254
RGD:14995489
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr5
C-C motif chemokine receptor 5
disease_progression
IMP
RGD
PMID:27859576
RGD:14401742
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cd14
CD14 antigen
treatment
ISO
RGD
PMID:23277536
RGD:407424596
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd36
CD36 molecule
IMP
RGD
PMID:24280415
RGD:11041117
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cd68
CD68 antigen
treatment
ISO
RGD
PMID:23277536 PMID:29399060
RGD:407424596 , RGD:407424599
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
G
Crp
C-reactive protein, pentraxin-related
ISO
protein:increased expression:serum:
RGD
PMID:21806828
RGD:9491781
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Ctsb
cathepsin B
ISO
protein:increased activity:liver, cytosol (rat)
RGD
PMID:17850215
RGD:2315516
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
Cxcl1
C-X-C motif chemokine ligand 1
ameliorates
IEP
RGD
PMID:33710653
RGD:401976495
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO IMP IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26428356 PMID:24064383 PMID:25583360
RGD:14700870 , RGD:14700884
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Dnmt1
DNA methyltransferase 1
IMP
RGD
PMID:22905112
RGD:9588654
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Fkbp5
FK506 binding protein 5
ameliorates
IMP ISO
mRNA,protein:incrased expression:liver (human)
RGD
PMID:33710653 PMID:33710653
RGD:401976495 , RGD:401976495
NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
G
Foxo1
forkhead box O1
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
G
Hamp
hepcidin antimicrobial peptide
ISO
mRNA:decreased expression:liver
RGD
PMID:19253830
RGD:11041633
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Lbp
lipopolysaccharide binding protein
treatment
ISO
RGD
PMID:23277536
RGD:407424596
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
G
Ldlr
low density lipoprotein receptor
IEP
protein:decreased expression: liver (rat)
RGD
PMID:20028367
RGD:21410185
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
G
Mir155
microRNA 155
IMP
RGD
PMID:26867493
RGD:25671474
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Nlrc5
NLR family, CARD domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36708882
NCBI chr 8:95,160,963...95,253,900
Ensembl chr 8:95,160,984...95,253,900
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
treatment
ISO
RGD
PMID:26256083
RGD:11522097
NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
G
Ocln
occludin
treatment
ISO
RGD
PMID:31116255
RGD:407424600
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
G
Pemt
phosphatidylethanolamine N-methyltransferase
ISO
RGD
PMID:17156888
RGD:1642369
NCBI chr11:59,861,440...59,937,394
Ensembl chr11:59,861,440...59,937,315
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18703563
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
treatment
ISO
RGD
PMID:29399060 PMID:31116255
RGD:407424599 , RGD:407424600
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:25561792
RGD:11075083
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
ISO
protein:decreased expression:liver
RGD
PMID:18996124
RGD:2312349
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Sod1
superoxide dismutase 1, soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19951287
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
RGD
PMID:11477087
RGD:1625694
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Stat4
signal transducer and activator of transcription 4
ISO
RGD
PMID:18296740
RGD:7207884
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Tead1
TEA domain family member 1
ameliorates
IEP
RGD
PMID:33710653
RGD:401976495
NCBI chr 7:112,278,563...112,505,991
Ensembl chr 7:112,278,525...112,506,014
G
Tgfb1
transforming growth factor, beta 1
treatment
ISO
RGD
PMID:29399060
RGD:407424599
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tjp1
tight junction protein 1
treatment
ISO
RGD
PMID:23277536
RGD:407424596
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
G
Tlr2
toll-like receptor 2
treatment
ISO
RGD
PMID:23277536
RGD:407424596
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
severity treatment
IMP ISO
RGD
PMID:29884546 PMID:23277536 PMID:21463341
RGD:14697697 , RGD:407424596 , RGD:14700554
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
susceptibility treatment
ISO
DNA:SNP:promoter:-238G>A (human)
RGD
PMID:9214463 PMID:20143470 PMID:29399060
RGD:14995434 , RGD:38508901 , RGD:407424599
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Ubd
ubiquitin D
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr17:37,504,783...37,506,992
Ensembl chr17:37,504,783...37,506,986
G
Abcb11
ATP-binding cassette, sub-family B member 11
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Agt
angiotensinogen
ISO
mRNA:decreased expression:liver
RGD
PMID:17258719
RGD:1601135
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Ahr
aryl-hydrocarbon receptor
ISO
protein:altered expression:hepatocyte
RGD
PMID:34082111
RGD:405866379
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Alb
albumin
severity
ISO
protein:increased expression, modification:urine
RGD
PMID:29369844
RGD:14694842
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Atg7
autophagy related 7
IEP
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
G
Becn1
beclin 1, autophagy related
IEP
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Ccl2
C-C motif chemokine ligand 2
severity
ISO IMP
RNA:increased expression:liver:
RGD
PMID:24429361 PMID:21826694 PMID:10446112
RGD:14975280 , RGD:14995491 , RGD:14995467
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl3
C-C motif chemokine ligand 3
severity
ISO
RGD
PMID:10446112
RGD:14995467
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccl5
C-C motif chemokine ligand 5
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12586603 PMID:31258651
RGD:14995304
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Col1a1
collagen, type I, alpha 1
ISO
RGD
PMID:1670041
RGD:5688335
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Cpt1a
carnitine palmitoyltransferase 1a, liver
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
G
Cxcl15
C-X-C motif chemokine ligand 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26220752
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cyp7a1
cytochrome P450, family 7, subfamily a, polypeptide 1
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
G
Ddr1
discoidin domain receptor family, member 1
disease_progression severity
IEP ISO
mRNA:increased expression:liver (mouse) mRNA:increased expression:liver (human)
RGD
PMID:33173221 PMID:33173221
RGD:151347691 , RGD:151347691
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
G
Fas
Fas cell surface death receptor
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fgf15
fibroblast growth factor 15
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
G
Icam1
intercellular adhesion molecule 1
severity
ISO
protein:increased expression:hepatocyte
RGD
PMID:1347281
RGD:14402038
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Il13
interleukin 13
ISO
mRNA:increased expression:liver
RGD
PMID:16698589
RGD:1581860
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il18
interleukin 18
severity
ISO
associated alcoholic liver cirrhosis; protein:increased expression:plasma:
RGD
PMID:15566508
RGD:14696666
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Mir155
microRNA 155
ameliorates
ISO IMP
RNA:increased expression:liver
RGD
PMID:32317960 PMID:31090940
RGD:151347420 , RGD:407445926
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mtor
mechanistic target of rapamycin kinase
IEP
protein:decreased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nlrp3
NLR family, pyrin domain containing 3
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
ISO
protein:altered expression:hepatocyte
RGD
PMID:34082111
RGD:405866379
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
G
Ppara
peroxisome proliferator activated receptor alpha
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Slc10a1
solute carrier family 10 (sodium/bile acid cotransporter family), member 1
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
G
Socs1
suppressor of cytokine signaling 1
ISO
mRNA:decreased expression:liver
RGD
PMID:32317960
RGD:151347420
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Sqstm1
sequestosome 1
IEP
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
G
Srebf1
sterol regulatory element binding transcription factor 1
treatment
ISO
RGD
PMID:27939985
RGD:15036816
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Sts
steroid sulfatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26220752
NCBI chr X:168,856,332...169,015,037
Ensembl chr X:168,909,030...169,014,924
G
Sult1e1
sulfotransferase family 1E, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26220752
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Tnf
tumor necrosis factor
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12586603 PMID:27939985
RGD:15036816
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Arc
activity regulated cytoskeletal-associated protein
disease_progression
IEP
mRNA:altered expression:brain (mouse)
RGD
PMID:26708208
RGD:401853772
NCBI chr15:74,540,930...74,544,419
Ensembl chr15:74,540,932...74,544,419
G
Bdnf
brain derived neurotrophic factor
IEP
mRNA,protein:decreased expression:cerebellum
RGD
PMID:19861148
RGD:401965398
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Drd2
dopamine receptor D2
treatment
ISO
RGD
PMID:28300818
RGD:13506954
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Fos
FBJ osteosarcoma oncogene
ISO
protein:altered expression:brain mRNA:decreased expression:adrenal gland
RGD
PMID:26727528 PMID:12351928
RGD:405101372 , RGD:405255666
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Gdnf
glial cell line derived neurotrophic factor
IEP
mRNA:decreased expression:basal nucleus
RGD
PMID:24061482
RGD:405850213
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Ifng
interferon gamma
treatment
IMP
RGD
PMID:9514301
RGD:10755766
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ngf
nerve growth factor
IEP ISO
mRNA,protein:increased expression:cerebellum protein:increased expression:plasma
RGD
PMID:19861148 PMID:18639986
RGD:401965398 , RGD:401965411
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Nps
neuropeptide S
ISO
RGD
PMID:19860802
RGD:9831199
NCBI chr 7:134,870,348...134,874,671
Ensembl chr 7:134,860,432...134,874,671
G
Npsr1
neuropeptide S receptor 1
ISO
mRNA:increased expression:brain
RGD
PMID:19860802
RGD:9831199
NCBI chr 9:24,009,212...24,229,151
Ensembl chr 9:24,009,292...24,227,694
G
Ntrk1
neurotrophic tyrosine kinase, receptor, type 1
IEP
mRNA,protein:increased expression:cerebellum
RGD
PMID:19861148
RGD:401965398
NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
IEP
mRNA:increased expression:basal nucleus, cerebral cortex
RGD
PMID:24061482
RGD:405850213
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Per2
period circadian clock 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15608650
NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
susceptibility
ISO
DNA:missense mutation:cds:p.E504K (human) DNA:missense mutation:cds: (rs671) (human) associated with alcohol dependence;DNA:missense mutation:exon 12:p.E487K (human)
RGD
PMID:29779728 PMID:23550892 PMID:11051375
RGD:14696777 , RGD:15042864 , RGD:15042858
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Bcl2
B cell leukemia/lymphoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
protein:decreased expression:brain
RGD
PMID:16205370
RGD:6483345
NCBI chr11:100,465,765...100,472,565
Ensembl chr11:100,465,730...100,482,555
G
Col3a1
collagen, type III, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Crp
C-reactive protein, pentraxin-related
severity
ISO
RGD
PMID:22441510
RGD:6482305
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20843640 PMID:29404441
RGD:14700873
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Ddr1
discoidin domain receptor family, member 1
severity
ISO
mRNA:increased expression:liver (human)
RGD
PMID:33173221
RGD:151347691
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
G
Ddr2
discoidin domain receptor family, member 2
disease_progression ameliorates
ISO
RGD
PMID:21199726 PMID:23409069
RGD:150429766 , RGD:150517731
NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
G
Fabp2
fatty acid binding protein 2, intestinal
onset
ISO
DNA:polymorphism:CDS:amino acid A54T, homozygosity of the T allele associated with later onset
RGD
PMID:16289894
RGD:1578455
NCBI chr 3:122,688,721...122,693,155
Ensembl chr 3:122,688,721...122,693,155
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
susceptibility
ISO
DNA:SNP:intron 8:84435G>A (human)
RGD
PMID:19428381
RGD:402463950
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Il18bp
interleukin 18 binding protein
ISO
protein:increased expression:plasma:
RGD
PMID:15566508
RGD:14696666
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Jak2
Janus kinase 2
ISO
mRNA, protein:increased expression, increased tyrosine phosphorylation:liver
RGD
PMID:24619965
RGD:10403061
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Lep
leptin
IDA
DNA:hypomethylation:promoter (human)
RGD
PMID:29912265
RGD:21201248
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Mboat7
membrane bound O-acyltransferase domain containing 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482880
NCBI chr 7:3,680,788...3,696,188
Ensembl chr 7:3,680,788...3,696,522
G
Mir122
microRNA 122
ISO
miRNA:decreased expression:liver
RGD
PMID:28987423
RGD:14401600
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir141
microRNA 141
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 6:124,694,877...124,694,948
Ensembl chr 6:124,694,877...124,694,948
G
Mir17
microRNA 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:115,281,103...115,281,186
Ensembl chr14:115,281,103...115,281,186
G
Mir193b
microRNA 193b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:13,267,387...13,267,465
Ensembl chr16:13,267,387...13,267,465
G
Mir338
microRNA 338
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:119,905,591...119,905,688
Ensembl chr11:119,905,591...119,905,688
G
Mir421
microRNA 421
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:102,616,527...102,616,602
Ensembl chr X:102,616,527...102,616,602
G
Mir423
microRNA 423
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
G
Mir483
microRNA 483
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:142,208,661...142,208,733
Ensembl chr 7:142,208,661...142,208,733
G
Mir484
microRNA 484
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:13,977,490...13,977,556
Ensembl chr16:13,977,490...13,977,556
G
Mir532
microRNA 532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:7,114,641...7,114,736
Ensembl chr X:7,114,641...7,114,736
G
Mir93
microRNA 93
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:138,163,785...138,163,872
Ensembl chr 5:138,163,785...138,163,872
G
Mmp13
matrix metallopeptidase 13
ISO
RGD
PMID:16286264
RGD:10043176
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19731237 PMID:23274713
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNP: :677C>T(human)
RGD
PMID:25987440
RGD:14696749
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
ISO
RGD
PMID:24497272
RGD:10448995
NCBI chr11:98,658,758...98,666,233
Ensembl chr11:98,658,758...98,666,159
G
Plau
plasminogen activator, urokinase
ISO
RGD
PMID:19615318
RGD:7241800
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Pnpla3
patatin-like phospholipase domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19946271 PMID:26482880
NCBI chr15:84,052,017...84,073,720
Ensembl chr15:84,052,038...84,071,437
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
susceptibility
ISO
DNA:polymorphism:promoter:
RGD
PMID:25987440
RGD:14696749
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
ISO
protein:increased expression:serum (human)
RGD
PMID:27748324
RGD:27226704
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Smad3
SMAD family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Sod2
superoxide dismutase 2, mitochondrial
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: : 47T>C(human)
CTD RGD
PMID:19731237 PMID:26873981
RGD:11060603
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Tg
thyroglobulin
ISO
RGD
PMID:6883738
RGD:401976502
NCBI chr15:66,542,606...66,722,570
Ensembl chr15:66,542,602...66,722,570
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Timp1
tissue inhibitor of metalloproteinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Tlr9
toll-like receptor 9
ISO
protein:increased expression:blood, neutrophil (human)
RGD
PMID:18433921
RGD:5130706
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tm6sf2
transmembrane 6 superfamily member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482880
NCBI chr 8:70,525,574...70,532,716
Ensembl chr 8:70,525,574...70,532,716
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Ace
angiotensin I converting enzyme
severity treatment
ISO
protein:increased activity:serum (human)
RGD
PMID:3028446 PMID:28691216
RGD:19165343 , RGD:40400719
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Adipor2
adiponectin receptor 2
treatment
ISO
RGD
PMID:24797033
RGD:25824940
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
G
Ahr
aryl-hydrocarbon receptor
exacerbates ameliorates
IMP IDA
RGD
PMID:34454169 PMID:36871955
RGD:405866377 , RGD:405866378
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
susceptibility severity
ISO IMP
DNA:missense mutation:cds, exon 12:p.E487K (human) DNA:polymorphism:exon 12: (human) DNA:deletion:cds: (mouse)
RGD
PMID:1916152 PMID:12198368 PMID:26173414 PMID:3189338
RGD:14696699 , RGD:14981580 , RGD:11076022 , RGD:14696790
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Angpt2
angiopoietin 2
severity
ISO
RGD
PMID:24959006
RGD:15014784
NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578
G
Atg7
autophagy related 7
IEP
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
G
Becn1
beclin 1, autophagy related
IEP
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
C6
complement component 6
resistance
ISO
RGD
PMID:15351314
RGD:1600673
NCBI chr15:4,756,550...4,833,527
Ensembl chr15:4,756,657...4,844,449
G
Cat
catalase
treatment
ISO
RGD
PMID:8370342 PMID:28898587
RGD:405255646 , RGD:405255658
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cav1
caveolin 1, caveolae protein
treatment
ISO
RGD
PMID:23764359
RGD:8662277
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Cd27
CD27 antigen
ISO
RGD
PMID:16698589
RGD:1581860
NCBI chr 6:125,209,583...125,214,014
Ensembl chr 6:125,209,585...125,213,973
G
Cd59a
CD59a antigen
ISO
protein:decreased expression:liver
RGD
PMID:12483994
RGD:1600486
NCBI chr 2:103,926,177...103,945,755
Ensembl chr 2:103,926,146...103,945,699
G
Cd59b
CD59b antigen
ISO
protein:decreased expression:liver
RGD
PMID:12483994
RGD:1600486
NCBI chr 2:103,900,127...103,920,619
Ensembl chr 2:103,896,142...103,921,534
G
Cldn1
claudin 1
treatment
ISO
RGD
PMID:31116255
RGD:407424600
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNP::-318 T>C(rs5742909)(human)
RGD
PMID:15208156
RGD:14398728
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl5
C-X-C motif chemokine ligand 5
ISO
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
treatment
IEP ISO
RGD
PMID:29401608 PMID:9927612 PMID:30192013 PMID:25592162 PMID:29902864
RGD:14700887 , RGD:405650696 , RGD:14700906 , RGD:14700894 , RGD:14700893
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Egfr
epidermal growth factor receptor
IMP
RGD
PMID:30502657
RGD:38599215
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Eif2s1
eukaryotic translation initiation factor 2, subunit 1 alpha
ISO
RGD
PMID:21059295
RGD:10395351
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:lymphocyte:
RGD
PMID:26429926
RGD:14700711
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fkbp5
FK506 binding protein 5
ISO
mRNA,protein:incrased expression:liver (human)
RGD
PMID:33710653
RGD:401976495
NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
G
Gdnf
glial cell line derived neurotrophic factor
ISO IEP
protein:increased expression:serum mRNA,protein:increased expression:liver
RGD
PMID:35338490 PMID:35338490
RGD:405849393 , RGD:405849393
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Gstm1
glutathione S-transferase, mu 1
ISO
RGD
PMID:15932176 PMID:26937962
RGD:14700973 , RGD:11060494
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstt1
glutathione S-transferase, theta 1
ISO
RGD
PMID:15932176 PMID:26937962
RGD:14700973 , RGD:11060494
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Hfe
homeostatic iron regulator
ISO
mRNA:increased expression:liver, Kupffer cell (rat)
RGD
PMID:18599584
RGD:8694397
NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837
G
Hif1a
hypoxia inducible factor 1, alpha subunit
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:17085342
RGD:9068897
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Igf2
insulin-like growth factor 2
ISO
mRNA:increased expression:liver
RGD
PMID:18505416
RGD:5510002
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:serum (rat)
RGD
PMID:23009062
RGD:7204488
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
treatment
ISO
RGD
PMID:31116255
RGD:407424600
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Keap1
kelch-like ECH-associated protein 1
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:22459801
RGD:6892954
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Lpl
lipoprotein lipase
treatment
ISO
RGD
PMID:28442378
RGD:13794376
NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
protein:increased expression:liver
RGD
PMID:11798463
RGD:1642007
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mir122
microRNA 122
IEP
miRNA:decreased expression:hepatocyte
RGD
PMID:28987423
RGD:14401600
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir155
microRNA 155
ameliorates
IEP ISO IMP
RNA:increased expression:liver
RGD
PMID:28492308 PMID:31090940 PMID:31090940
RGD:25314298 , RGD:407445926 , RGD:407445926
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir223
microRNA 223
severity
IMP
RGD
PMID:27679493
RGD:21408575
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:liver
RGD
PMID:17374579
RGD:1642042
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mtor
mechanistic target of rapamycin kinase
IEP ISO
protein:decreased expression:liver
RGD
PMID:31090940 PMID:31090940
RGD:407445926 , RGD:407445926
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Myc
myelocytomatosis oncogene
disease_progression severity
ISO IMP
mRNA:increased expression:liver
RGD
PMID:26576483 PMID:26576483
RGD:14695016 , RGD:14695016
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Nedd8
neural precursor cell expressed, developmentally down-regulated gene 8
ISO
RGD
PMID:12533840
RGD:1549458
NCBI chr14:55,899,720...55,909,337
Ensembl chr14:55,899,720...55,909,581
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment severity
IEP ISO
DNA:SNP:promoter:rs35652124(human)
RGD
PMID:31906014 PMID:31340446
RGD:21201307 , RGD:21201311
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
ameliorates
IDA
RGD
PMID:34082111
RGD:405866379
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Otc
ornithine transcarbamylase
ISO
protein:increased expression:serum (rat)
RGD
PMID:19101528
RGD:4144059
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
G
Plaur
plasminogen activator, urokinase receptor
ISO
protein:increased expression:serum
RGD
PMID:22098627
RGD:6484116
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
G
Pnpla3
patatin-like phospholipase domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19946271
NCBI chr15:84,052,017...84,073,720
Ensembl chr15:84,052,038...84,071,437
G
Ppara
peroxisome proliferator activated receptor alpha
severity
IAGP
DNA:knockout::increased severity in knockouts
RGD
PMID:15382117
RGD:5683636
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Ppard
peroxisome proliferator activator receptor delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27765815
NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448
G
Psmd14
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14
ISO
protein:decreased expression:liver, cytosolic proteasome complex (rat)
RGD
PMID:19609968
RGD:9480236
NCBI chr 2:61,542,038...61,630,720
Ensembl chr 2:61,542,038...61,630,720
G
Rbp4
retinol binding protein 4, plasma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762690
NCBI chr19:38,105,068...38,113,769
Ensembl chr19:38,105,077...38,113,729
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
IEP
protein:increased phosphorylation:liver
RGD
PMID:35338490
RGD:405849393
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Slc39a13
solute carrier family 39 (metal ion transporter), member 13
ISO
protein:increased expression:liver, endoplasmic reticulum (rat)
RGD
PMID:25767260
RGD:11553884
NCBI chr 2:90,892,136...90,900,754
Ensembl chr 2:90,892,136...90,900,762
G
Sod1
superoxide dismutase 1, soluble
treatment
ISO
human gene in a rat model
RGD
PMID:11266387
RGD:9587792
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
treatment
IEP
RGD
PMID:32236798
RGD:27095880
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18703563
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Sqstm1
sequestosome 1
IEP ISO
protein:increased expression:liver
RGD
PMID:31090940 PMID:31090940
RGD:407445926 , RGD:407445926
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
G
Tbxas1
thromboxane A synthase 1, platelet
ISO
mRNA,protein:increased expression:liver, Kupffer cell:
RGD
PMID:9262373
RGD:11059607
NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519
G
Tert
telomerase reverse transcriptase
IEP
mRNA,protein,activity:increased expression, increased activity:kupffer cell:
RGD
PMID:26725521
RGD:11574970
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Tlr3
toll-like receptor 3
treatment
IMP IDA
RGD
PMID:23023014 PMID:30870678
RGD:21079426 , RGD:21079436
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
G
Tnf
tumor necrosis factor
treatment
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:9397994 PMID:31116255 PMID:7556590 PMID:15670576
RGD:14398736 , RGD:407424600 , RGD:14995472 , RGD:14995456
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Uchl5
ubiquitin carboxyl-terminal esterase L5
ISO
protein:decreased expression:liver, cytosolic proteasome complex
RGD
PMID:19609968
RGD:9480236
NCBI chr 1:143,652,993...143,683,204
Ensembl chr 1:143,653,010...143,683,204
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:plasma
RGD
PMID:24959006
RGD:15014784
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Igf1
insulin-like growth factor 1
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igf2
insulin-like growth factor 2
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Cck
cholecystokinin
disease_progression
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:11185710
RGD:407419866
NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760
G
Cftr
cystic fibrosis transmembrane conductance regulator
ISO
DNA:missense mutations: :p.L1156F, Q1352H (human)
RGD
PMID:26089335
RGD:11566036
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Pthlh
parathyroid hormone-like peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22280800
NCBI chr 6:147,153,607...147,165,511
Ensembl chr 6:147,153,599...147,165,681
G
Ugt1a7c
UDP glucuronosyltransferase 1 family, polypeptide A7C
ISO
DNA:polymorphisms: :p.N129K, p.R131K, p.W208R (human)
RGD
PMID:12806614
RGD:2317503
NCBI chr 1:88,022,723...88,147,724
Ensembl chr 1:88,022,784...88,147,724
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Adh1
alcohol dehydrogenase 1 (class I)
ISO
mRNA:altered exxpression:liver (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
mRNA:altered exxpression:liver (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653
G
Bdnf
brain derived neurotrophic factor
ISO
protein:altered expression:amygdala, pyriform cortex, bed nucleus of stria terminalis
RGD
PMID:23588198
RGD:405849391
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
mRNA:decreased expression:adenohypophysis
RGD
PMID:11045867
RGD:407431640
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
IEP ISO
mRNA:altered exxpression:liver (rat) protein:increased expression, increased nitration
RGD
PMID:25236742 PMID:23413777 PMID:29404485 PMID:25236742
RGD:14700891 , RGD:405100715 , RGD:14700911 , RGD:14700891
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Dnmt1
DNA methyltransferase 1
IEP
protein:increased expression:nucleus accumbens:
RGD
PMID:23423140
RGD:9588287
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Drd1
dopamine receptor D1
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr13:54,205,202...54,209,677
Ensembl chr13:54,205,202...54,209,724
G
Drd2
dopamine receptor D2
ISO
mRNA:altered exxpression:spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Drd3
dopamine receptor D3
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
G
Drd4
dopamine receptor D4
susceptibility
ISO
DNA:repeats:exon: mRNA:altered exxpression:spleen (rat)
RGD
PMID:19393859 PMID:23413777
RGD:401960068 , RGD:405100715
NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
G
Efhd2
EF hand domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28397836
NCBI chr 4:141,585,453...141,602,231
Ensembl chr 4:141,585,453...141,602,231
G
Fos
FBJ osteosarcoma oncogene
ISO
protein:increased expression:prefrontal cortex
RGD
PMID:29407478
RGD:405295494
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr11:42,021,766...42,073,893
Ensembl chr11:42,021,766...42,073,757
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 5:71,115,735...71,253,192
Ensembl chr 5:71,114,940...71,253,192
G
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha 3
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr X:71,476,282...71,700,525
Ensembl chr X:71,476,287...71,700,454
G
Gabra6
gamma-aminobutyric acid type A receptor subunit alpha 6
ISO
mRNA:altered exxpression:spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr11:42,197,264...42,211,977
Ensembl chr11:42,197,264...42,211,899
G
Gdnf
glial cell line derived neurotrophic factor
ISO
protein:altered expression:amygdala, pyriform cortex, bed nucleus of stria terminalis
RGD
PMID:23298382 PMID:23588198
RGD:405849390 , RGD:405849391
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
G
Gpx1
glutathione peroxidase 1
ISO
protein:decreased expression:liver
RGD
PMID:25864381
RGD:401827870
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx3
glutathione peroxidase 3
ISO
protein:decreased expression:serum
RGD
PMID:25864381
RGD:401827870
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Gpx4
glutathione peroxidase 4
ISO
protein:decreased expression:liver
RGD
PMID:25864381
RGD:401827870
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
G
Grm2
glutamate receptor, metabotropic 2
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 9:106,521,733...106,533,308
Ensembl chr 9:106,520,294...106,533,281
G
Grm5
glutamate receptor, metabotropic 5
ISO
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 7:87,233,212...87,784,271
Ensembl chr 7:87,233,376...87,784,115
G
Mir125a
microRNA 125a
ISO
RNA:decreased expression:neuron
RGD
PMID:27085842
RGD:26884454
NCBI chr17:18,051,074...18,051,141
Ensembl chr17:18,051,074...18,051,141
G
Mir223
microRNA 223
ISO IEP
RNA:increased expression:serum RNA:increased expression:serum, neutrophil,liver
RGD
PMID:27679493 PMID:27679493
RGD:21408575 , RGD:21408575
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Npy1r
neuropeptide Y receptor Y1
ameliorates
IMP IEP
protein:decreased expression:central amygdaloid nucleus (mouse)
RGD
PMID:30647448 PMID:22218088
RGD:402463940 , RGD:405096664
NCBI chr 8:67,149,595...67,159,452
Ensembl chr 8:67,149,844...67,159,444
G
Oprl1
opioid receptor-like 1
ISO
RGD
PMID:29197086
RGD:14348965
NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
G
Per2
period circadian clock 2
ISO
DNA, mRNA:hypermethylation, decreased expression:blood
RGD
PMID:30597578
RGD:405878075
NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046
G
Pomc
pro-opiomelanocortin-alpha
ISO
DNA, mRNA:hypermethylation, decreased expression:blood mRNA:decreased expression:hypothalamus
RGD
PMID:30597578 PMID:11045867
RGD:405878075 , RGD:407431640
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Sirt1
sirtuin 1
ISO
RGD
PMID:24416161
RGD:9495933
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Slc23a2
solute carrier family 23 (nucleobase transporters), member 2
ISO
RGD
PMID:27085842
RGD:26884454
NCBI chr 2:131,894,416...131,987,287
Ensembl chr 2:131,894,416...131,987,028
G
Ank3
ankyrin 3, epithelial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
Apoe
apolipoprotein E
IMP
RGD
PMID:15007105
RGD:12904641
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Bpifa1
BPI fold containing family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr 2:153,984,800...153,991,137
Ensembl chr 2:153,984,800...153,991,139
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Dio3
deiodinase, iodothyronine type III
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr12:110,245,664...110,247,531
Ensembl chr12:110,245,502...110,247,531
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Dnmt3b
DNA methyltransferase 3B
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
Drd2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Ehmt2
euchromatic histone lysine N-methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr17:35,117,427...35,133,049
Ensembl chr17:35,117,445...35,133,028
G
Gabrb3
GABRB3, gamma-aminobutyric acid type A receptor subunit beta 3
treatment sexual_dimorphism
ISO IEP
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 , RGD:405866345
NCBI chr 7:57,240,266...57,478,550
Ensembl chr 7:57,069,440...57,478,550
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
Hdac2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Hdac4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
G
Igf1
insulin-like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Mat2a
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 6:72,409,779...72,416,539
Ensembl chr 6:72,409,782...72,416,541
G
Mecp2
methyl CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893 PMID:23763370
RGD:11344152 , RGD:13432044
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,129,296
G
Mir326
microRNA 326
ISO
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 7:99,201,476...99,201,570
Ensembl chr 7:99,201,476...99,201,570
G
Mir7b
microRNA 7b
ISO
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr17:56,549,988...56,550,098
Ensembl chr17:56,549,988...56,550,098
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
G
Nos1
nitric oxide synthase 1, neuronal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat) associated with adrenalectomy, chronic stress, female; mRNA:increased expression:prefrontal cortex (rat)
RGD
PMID:29251811 PMID:30367959
RGD:401965484 , RGD:401966864
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
Oprk1
opioid receptor, kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
Oprl1
opioid receptor-like 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
G
Pdyn
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
G
Per2
period circadian clock 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046
G
Pnoc
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr14:65,638,931...65,662,908
Ensembl chr14:65,638,122...65,662,921
G
Pomc
pro-opiomelanocortin-alpha
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Prl
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Pten
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 9:89,791,565...89,909,032
Ensembl chr 9:89,791,961...89,909,030
G
Rps6ka1
ribosomal protein S6 kinase polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 4:133,574,601...133,615,466
Ensembl chr 4:133,574,601...133,615,108
G
Setd7
SET domain containing (lysine methyltransferase) 7
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 3:51,422,740...51,468,519
Ensembl chr 3:51,422,740...51,468,300
G
Slc25a12
solute carrier family 25 (mitochondrial carrier, Aralar), member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 2:71,104,614...71,198,125
Ensembl chr 2:71,101,407...71,198,093
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Tlr4
toll-like receptor 4
ameliorates
IMP
RGD
PMID:30312858
RGD:405866345
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Ube3a
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 7:58,871,891...58,960,585
Ensembl chr 7:58,878,498...58,961,284
G
Rhoa
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Fos
FBJ osteosarcoma oncogene
treatment
ISO
RGD
PMID:8229066
RGD:405100718
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
mRNA, protein:increased expression:medial thalamic group, inferior colliculus, neuron
RGD
PMID:18481165
RGD:2300278
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Tkt
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3762968
NCBI chr14:30,271,088...30,296,681
Ensembl chr14:30,270,316...30,296,677
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all